SEED INNOVATIONS LIMITED

M&A Activity • May 25, 2022

National Storage Mechanism | Additional information

RNS Number : 8067M

Seed Innovations Limited

25 May 2022

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

25 May 2022

SEED Innovations Limited ('SEED' or the 'Company')

Investee Company Update: Yooma Wellness Inc.

SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, notes that following its suspension of trading announced on 4 May 2022, investee company Yooma Wellness Inc. ('Yooma') has been reinstated for trading on the Canadian Securities Exchange ('CSE'), with immediate effect.

Yooma is a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands. SEED has a holding of 4,427,609 ordinary shares in Yooma representing approximately 4.4% of Yooma's issued share capital.

About Yooma Wellness Inc.

Yooma's mission is to build a vertically-integrated global leader in the manufacturing, marketing, distribution, and sale of wellness products including hemp seed oil and hemp-derived and cannabinoid (CBD) ingredients. The company leverages strategically curated sales channels and ecommerce networks to deliver a diverse mix of wellness products through operating subsidiaries in the United States, United Kingdom, France and Japan. Learn more at  www.yooma.ca

***ENDS***

For further information on the Company please visit  www.seedinnovations.co  or contact:

Ed McDermott Lance de Jersey	SEED Innovations Ltd	E: info@seedinnovations.co
James Biddle Roland Cornish	Beaumont   Cornish   Limited, Nomad	T: (0)20 7628 3396
Isabella Pierre Damon Heath	Shard Capital Partners LLP Broker	T: (0)20 7186 9927
Catherine Leftley Isabelle Morris	St Brides Partners Ltd, Financial PR	E: info@stbridespartners.co.uk

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFLFIVEVIEFIF